neurofibromatosis type II
ICD-10: D33MeSH: D016518ORPHA: 637
Overview
type of neurofibromatosis disease
Available Treatments (0)
No treatments linked yet
Clinical trials or compassionate use may be available — consult a specialist.
Clinical Presentation
Signs and symptoms associated with neurofibromatosis type II, sourced from HPO and Orphanet clinical annotations.
NeuromaSensorineural hearing impairmentAbnormality of the eyeMyelopathyMeningiomaReduced visual acuityPosterior subcapsular cataractBilateral vestibular schwannomaPeripheral schwannomaSpinal cord tumorIntracranial meningiomaHyperesthesiaHydrocephalusTinnitusVisual lossAbnormal optic nerve morphologyBlindnessAmblyopiaDiplopiaSensory neuropathyHyperpigmentation of the skinSeizureDysarthriaHemiparesisPolyneuropathyAbnormal cerebellum morphologyDysphagiaPostural instabilityUnsteady gaitMemory impairmentBrain stem compressionEpendymomaSomatic sensory dysfunctionCranial nerve paralysisNeoplasm of the skinFoot dorsiflexor weaknessRetinal hamartomaMononeuropathyFacial palsyWrist dropSpinal meningiomaEpiretinal membraneCortical cataractAphasiaRemnants of the hyaloid vascular systemAstrocytomaGlioma
Classification & Codes
ICD-10 Code
D33MeSH Code
D016518Orphanet Code
ORPHA:637neurofibromatosis type II
| ICD-10 | D33 |
| MeSH | D016518 |
| Orphanet | ORPHA:637 |
| Treatments | 0 drug(s) |
| Symptoms on record | 47 signs |
| Status | published |
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO